Data from @ Prostate Cancer Prevention Trial placebo arm biopsies ( @ individuals ) , where prostate-specific antigen and digital rectal examination results were available within @ year before the biopsy and PSA was @ ng/mL , were used to develop a nominal logistic regression model to predict the risk of no vs low-grade ( Gleason grade < @ ) vs high-grade cancer ( Gleason grade@ ) .